Ernest Turner

601 total citations
22 papers, 478 citations indexed

About

Ernest Turner is a scholar working on Genetics, Hematology and Physiology. According to data from OpenAlex, Ernest Turner has authored 22 papers receiving a total of 478 indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Genetics, 18 papers in Hematology and 7 papers in Physiology. Recurrent topics in Ernest Turner's work include Hemoglobinopathies and Related Disorders (18 papers), Iron Metabolism and Disorders (13 papers) and Erythrocyte Function and Pathophysiology (5 papers). Ernest Turner is often cited by papers focused on Hemoglobinopathies and Related Disorders (18 papers), Iron Metabolism and Disorders (13 papers) and Erythrocyte Function and Pathophysiology (5 papers). Ernest Turner collaborates with scholars based in United States, Germany and Peru. Ernest Turner's co-authors include Toshio Asakura, Maciej S. Buchowski, Paul J. Flakoll, Cyril O. Enwonwu, Darleen Powars, Myfanwy J. Borel, Gary D. Overturf, Richard E. Goldstein, Benjamin B. Peeler and H. Fasold and has published in prestigious journals such as Blood, American Journal of Clinical Nutrition and PEDIATRICS.

In The Last Decade

Ernest Turner

21 papers receiving 425 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ernest Turner United States 12 336 278 73 68 60 22 478
Andrew Deiss United States 9 93 0.3× 138 0.5× 76 1.0× 42 0.6× 96 1.6× 13 426
John Sherwin United States 13 91 0.3× 92 0.3× 47 0.6× 204 3.0× 170 2.8× 24 529
Robin Williams Australia 6 150 0.4× 169 0.6× 136 1.9× 48 0.7× 158 2.6× 10 537
Wen Qü China 11 51 0.2× 172 0.6× 44 0.6× 32 0.5× 96 1.6× 78 437
Huisman Th Netherlands 8 351 1.0× 255 0.9× 103 1.4× 132 1.9× 72 1.2× 25 487
Egil Amundsen Norway 7 114 0.3× 29 0.1× 25 0.3× 34 0.5× 61 1.0× 9 343
C. C. Armsby United States 10 185 0.6× 107 0.4× 207 2.8× 50 0.7× 229 3.8× 12 629
F. Stanley Porter United States 14 42 0.1× 72 0.3× 60 0.8× 95 1.4× 281 4.7× 21 625
Ototaka Higashi Japan 10 32 0.1× 120 0.4× 59 0.8× 21 0.3× 101 1.7× 30 408
Peter Sizeland New Zealand 8 21 0.1× 39 0.1× 47 0.6× 38 0.6× 76 1.3× 10 317

Countries citing papers authored by Ernest Turner

Since Specialization
Citations

This map shows the geographic impact of Ernest Turner's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ernest Turner with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ernest Turner more than expected).

Fields of papers citing papers by Ernest Turner

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ernest Turner. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ernest Turner. The network helps show where Ernest Turner may publish in the future.

Co-authorship network of co-authors of Ernest Turner

This figure shows the co-authorship network connecting the top 25 collaborators of Ernest Turner. A scholar is included among the top collaborators of Ernest Turner based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ernest Turner. Ernest Turner is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Roa, D, et al.. (2013). Búsqueda de hemoglobinas anormales en los recién nacidos en las grandes alturas.. Revista Médica Herediana. 8(3). 87–87.
2.
Turner, Ernest, et al.. (2003). Niprisan (Nix‐0699) improves the survival rates of transgenic sickle cell mice under acute severe hypoxic conditions. British Journal of Haematology. 122(6). 1001–1008. 49 indexed citations
3.
Adunyah, Samuel E., H. Fasold, Kazumi Horiuchi, et al.. (2003). Combined use of nonmyelosuppressive nitrosourea analogues with hydroxyurea in the induction of F-cell production in a human erythroleukemic cell line. Experimental Hematology. 31(7). 592–600. 5 indexed citations
4.
Turner, Ernest, et al.. (2002). In vitro effects of NIPRISAN (Nix‐0699): a naturally occurring, potent antisickling agent. British Journal of Haematology. 118(1). 337–343. 68 indexed citations
5.
Fasold, H., et al.. (2001). Hydroxyurea-induced oxidative damage of normal and sickle cell hemoglobins in vitro: Amelioration by radical scavengers. Journal of Clinical Laboratory Analysis. 15(1). 1–7. 14 indexed citations
6.
Buchowski, Maciej S., et al.. (2001). Increased bone turnover is associated with protein and energy metabolism in adolescents with sickle cell anemia. American Journal of Physiology-Endocrinology and Metabolism. 280(3). E518–E527. 17 indexed citations
7.
8.
Buchowski, Maciej S., et al.. (2000). Plasma Leptin Association with Body Composition and Energy Expenditure in Sickle Cell Disease. Journal of the American College of Nutrition. 19(2). 228–236. 12 indexed citations
9.
Kutlar, F., et al.. (2000). HB Inkster [α85(F6)ASP→VAL] Found in a Caucasian male with Polycythemia. Hemoglobin. 24(4). 333–339. 2 indexed citations
10.
Kopsombut, Prapaporn, et al.. (1998). New isocratic high-performance liquid chromatographic procedure to assay the anti-sickling compound hydroxyurea in plasma with ultraviolet detection. Journal of Chromatography B Biomedical Sciences and Applications. 709(1). 119–126. 17 indexed citations
11.
Adunyah, Samuel E., et al.. (1998). Trimidox-Mediated Morphological Changes during Erythroid Differentiation Is Associated with the Stimulation of Hemoglobin and F-Cell Production in Human K562 Cells. Biochemical and Biophysical Research Communications. 247(3). 759–764. 8 indexed citations
12.
Turner, Ernest, et al.. (1998). Molecular Diagnosis and Characterization of Hb Zürich [β63(E7)His→Arg] Carriers in a Kentucky Family. Hemoglobin. 22(5-6). 509–515. 2 indexed citations
13.
Borel, Myfanwy J., Maciej S. Buchowski, Ernest Turner, et al.. (1998). Alterations in basal nutrient metabolism increase resting energy expenditure in sickle cell disease. American Journal of Physiology-Endocrinology and Metabolism. 274(2). E357–E364. 61 indexed citations
14.
Borel, Myfanwy J., Maciej S. Buchowski, Ernest Turner, Richard E. Goldstein, & Paul J. Flakoll. (1998). Protein turnover and energy expenditure increase during exogenous nutrient availability in sickle cell disease. American Journal of Clinical Nutrition. 68(3). 607–614. 38 indexed citations
15.
Turner, Ernest, et al.. (1997). Tiazofurin-induced autosecretion of IL-6 and hemoglobin production in K562 human leukemia cells. American Journal of Hematology. 54(4). 301–305. 6 indexed citations
16.
Turner, Ernest, et al.. (1992). Sickle cell disease with complicated influenza B virus infection.. PubMed. 84(6). 524–7. 3 indexed citations
17.
Enwonwu, Cyril O., et al.. (1990). Nitrogen Metabolism in Sickle Cell Anemia: Free Amino Acids in Plasma and Urine. The American Journal of the Medical Sciences. 300(6). 366–371. 63 indexed citations
18.
Powars, Darleen, Gary D. Overturf, & Ernest Turner. (1983). Is There an Increased Risk of Haemophilus influenzae Septicemia in Children with Sickle Cell Anemia?. PEDIATRICS. 71(6). 927–931. 55 indexed citations
19.
Turner, Ernest, et al.. (1979). Non-chromatographic radioimmunoassay procedure for urinary aldosterone.. Clinical Chemistry. 25(7). 1226–1229. 6 indexed citations
20.
Hall, Robert T., et al.. (1976). Protamine sulfate titration for heparin activity in neonates with indwelling umbilical catheters. The Journal of Pediatrics. 88(3). 467–472. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Andrew Deiss Breakdown of academic impact, for papers by John Sherwin Breakdown of academic impact, for papers by Robin Williams Breakdown of academic impact, for papers by Wen Qü Breakdown of academic impact, for papers by Huisman Th Breakdown of academic impact, for papers by Egil Amundsen Breakdown of academic impact, for papers by C. C. Armsby Breakdown of academic impact, for papers by F. Stanley Porter Breakdown of academic impact, for papers by Ototaka Higashi Breakdown of academic impact, for papers by Peter Sizeland
Rankless by CCL
2026